| Patents for C07C 225 - Compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly-bound oxygen atoms not being part of a cho group, e.g. amino ketones (4,302) |
|---|
| 03/11/2010 | US20100062460 Novel fluorochromes for organelle tracing and multi-color imaging |
| 03/10/2010 | EP1494642B1 Organosilicon derivatives of aminohydroxybenzophenones and their use as UV-A filters in cosmetic preparations |
| 03/02/2010 | US7671237 A tire tread rubber composition comprising a polymerized conjugated unsaturatedmonomer synthesized using an activator made by reacting m-diisopropenylbenzene with a tertiary alkyl lithium 100 degrees C. to produce a p-(N,N-dialkylamino)benzaldehyde or -ketone; materials handling |
| 02/24/2010 | CN100591660C Nonsteroic androgen acceptor regulators, preparation process, pharmaceutical composition and use thereof |
| 02/23/2010 | US7667078 Asymmetric reaction catalyst and method for preparing optically active compound using the same |
| 02/23/2010 | CA2562216C Process for producing a trifluoro-3-buten-2-one compound |
| 02/18/2010 | WO2010019469A2 Preparation of (s)-2-aminobutyric acid |
| 02/18/2010 | US20100040569 Photo-labile pro-fragrance conjugates |
| 02/17/2010 | CN101648883A Isoliquiritigenin derivant with antineoplastic activity and synthetic method thereof |
| 02/11/2010 | WO2010015692A2 Bupropion hydrobromide polymorphs |
| 02/11/2010 | CA2731041A1 Bupropion hydrobromide polymorphs |
| 02/04/2010 | US20100029968 Asymmetric reaction catalyst and method for preparing optically active compound using the same |
| 02/04/2010 | US20100029612 2-Aminoethyl Substituted Pyrimidin-2-Ones Cyclopropanes, Pyrazolines, Pyrimidines and Benzothiazepines and Their Uses as Urotensin II and Somatostatin 5 Receptor Ligands |
| 02/04/2010 | US20100029588 Substituted phenylamidines and the use thereof as fungicides |
| 01/27/2010 | CN100584816C Kutkin derivative, preparation method and application thereof |
| 01/19/2010 | US7649113 antiallergens for treating asthma, allergies, inflammatory conditions; side effect reduction; antiinflammatory agents |
| 01/14/2010 | WO2010004386A2 Amorphous bupropion hydrobromide and preparation thereof |
| 01/07/2010 | WO2010000856A1 Method for producing aminobiphenylene |
| 01/07/2010 | CA2728223A1 Method for producing aminobiphenyls |
| 01/06/2010 | EP2139848A1 Deuterium labelled ketamine |
| 01/05/2010 | US7642367 Diamino-functional chalcones |
| 01/05/2010 | US7642280 Inhibitors of acyl glucosaminyl inositol amidase and methods of use |
| 12/30/2009 | CN100575334C Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 12/24/2009 | US20090318714 Organic compounds |
| 12/23/2009 | CN100572356C Linking molecule for selective metallation of nucleic acid and its application |
| 12/16/2009 | CN101602681A Method for preparing derivatives of beta-enaminone and ester |
| 12/16/2009 | CN100569734C Organic compound containing heteroatoms and its use in Zigler-Natta catalyst |
| 12/10/2009 | US20090306216 Use of Beta-Aminoalcohols in the Treatment of Inflammatory Disorders and Pain |
| 12/10/2009 | US20090306110 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
| 12/10/2009 | US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 12/09/2009 | CN101597253A [N, N, O] and [O, N, O] type ligands, corresponding titanium complex containing same and application of titanium complex to ethylene polymerization catalysis |
| 12/09/2009 | CN100566713C Use of of aminosubstituted hydroxybenzophenones as photostable UV-filter in cosmetic and pharmaceutical preparations |
| 12/03/2009 | WO2009145219A1 Therapeutic agent for alzheimer's disease |
| 12/03/2009 | WO2009143714A1 2,4-dihydroxyl chalcone derivative, process for preparing them and use thereof |
| 12/03/2009 | CA2729812A1 Therapeutic agent for alzheimer's disease |
| 12/02/2009 | CN101591354A Functionalized ionic liquids, and methods of use thereof |
| 11/26/2009 | WO2009142967A1 Therapeutic prostaglandin compounds used as ocular hypotensive agents |
| 11/26/2009 | CA2724474A1 Therapeutic prostaglandin compounds used as ocular hypotensive agents |
| 11/25/2009 | EP2123628A1 A process for preparing optical pure milnacipran and its pharmaceutically accepted salts |
| 11/19/2009 | WO2009139922A2 Peptoid compositions and methods of using the same |
| 11/19/2009 | WO2009105218A3 Propiophenone derivatives |
| 11/18/2009 | CN100560563C Amfebutamone hydrochloride synthesizing process |
| 11/11/2009 | EP2114870A1 Synthetic ion channels |
| 11/11/2009 | EP1620475B1 Novel trifunctional photoinitiators |
| 11/11/2009 | EP1401451B1 Quinazoline derivatives which promote the release of parathyroid hormone |
| 11/11/2009 | CN101575253A Application of fullerene as catalyst in catalytic hydrogenation reaction of nitro aromatic compound |
| 11/11/2009 | CN100558698C Calcium receptor-active compounds |
| 11/05/2009 | WO2009100996A3 Process for preparing pyrazole functionalized benzodiazepinones |
| 11/03/2009 | CA2340670C An anthraquinone and its derivatives |
| 10/29/2009 | WO2009103534A3 Elansolids, novel natural metabolites of flexibacter and antibiotically active derivatives thereof |
| 10/28/2009 | EP2111223A1 Amine derivative compounds for treating ophthalmic diseases and disorders |
| 10/28/2009 | CN101565378A Preparation of derivative of dibenzoyl methane and application thereof |
| 10/28/2009 | CN100554234C Clear photopolymerizable systems for the preparation of high thickness coatings |
| 10/27/2009 | CA2406044C Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 10/21/2009 | CN101559062A Quinazoline derivatives which promote the release of parathyroid hormone |
| 10/20/2009 | US7605280 1,5-Bis-((2-dimethylamino-N-oxide)ethyl)amino)-4,8-dihydroxyanthracene-9,10-dione; DRAQ5 dyes;analyzing cells/biological material and detecting emitted fluorescence signal; cell permeant DNA-interactive agents providing a fluorescence signature into the infra red spectra; red-line emitting lasers |
| 10/13/2009 | CA2230047C Imide oligomers and co-oligomers containing pendent phenylethynyl groups and polymers therefrom |
| 10/08/2009 | WO2009123109A1 Photosensitive transparent resin composition, process for production of color filters, and color filters |
| 10/06/2009 | CA2482530C 3-aminophenol derivatives substituted in the 2-position, and dyes containing these compounds |
| 10/01/2009 | US20090246880 Method for preventing degradation of diacetylpolyamine |
| 09/30/2009 | CN101544671A Organic antimony compound bearing a sulfur-bridged ligand and its preparation and application |
| 09/24/2009 | WO2008139484A3 New process for the synthesis of loferpramine maleate: a stable salt of loferpramine |
| 09/23/2009 | CN101538213A Polymouphous substance of bupropion hydrobromic acid and preparation method thereof |
| 09/22/2009 | CA2209640C Cycloalkano-pyridines |
| 09/16/2009 | EP1437338B1 Luminous compounds and labeling reagents using the same |
| 09/15/2009 | US7589219 2,5-bis-diamine-[1,4]benzoquinonic derivatives, useful for the treatment of alzheimer's disease, method for preparing them and intermediates of said method |
| 09/08/2009 | US7586008 For inducing general anesthesia, sedation, and/or hypnotic or sleep effects in patient |
| 09/03/2009 | DE102008011685A1 Verfahren zur Herstellung von Ketonen aus alpha-Oxycarboxylaten und Arylbromiden Process for the preparation of ketones from alpha-aryl bromides and Oxycarboxylaten |
| 09/02/2009 | CN101519462A Tertiary amine co-synergist for photoinitiator and method for preparing same |
| 08/27/2009 | WO2009105218A2 Propiophenone derivatives |
| 08/27/2009 | US20090216015 Base Stable Ionic Liquids |
| 08/26/2009 | EP2091955A1 Alkoxy compounds for disease treatment |
| 08/25/2009 | US7579484 Method for the production of monoalkylamino ketones |
| 08/20/2009 | WO2009100996A2 Process for preparing pyrazole functionalized benzodiazepinones |
| 08/19/2009 | CN101508703A Organic bismuth ion compound containing bridge sulphur atom ligand, preparation and uses thereof |
| 08/11/2009 | US7572938 Precursors for ketones and aldehydes |
| 08/11/2009 | US7572935 Modified release formulations of a bupropion salt |
| 08/11/2009 | CA2174060C Inhibition of unsaturated monomers with 7-aryl quinone methides |
| 08/05/2009 | EP2084125A1 Aminobenzocycloheptene derivatives, methods for preparing the same and uses thereof in therapy |
| 08/05/2009 | CN101500984A Positively charged water-soluble prodrugs of ketoprofen and related compounds with very fast skin penetration rate |
| 08/05/2009 | CN101500983A Positively charged water-soluble prodrugs of diflunisal and related compounds with very fast skin penetration rate |
| 08/05/2009 | CN100522913C High density optical disk and its compound for recording |
| 07/23/2009 | WO2009089680A1 Method of modulating membrane potential of a cell |
| 07/23/2009 | US20090187028 Process for preparing Chiral Dipeptidyl Peptidase -IV Inhibitor Intermediates |
| 07/23/2009 | US20090186790 Photo-labile pro-fragrance conjugates |
| 07/22/2009 | EP1542981B1 Process for the preparation of 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiazoles from cyclohexanes and cyclohexanones as intermediates |
| 07/16/2009 | US20090181971 Inhibitors of Histone Deacetylase |
| 07/14/2009 | US7560582 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants |
| 07/09/2009 | US20090175809 Merocyanine derivatives for cosmetic use |
| 07/02/2009 | DE102007063056A1 New anthraquinone derivatives are protein kinase inhibitors useful e.g. to treat autoimmune-, inflammatory-, metabolic-, organ-, cardiovascular-, neurological and neurodegenerative-, hormone dependent-disease, asthma, depression and stroke |
| 07/01/2009 | EP2075245A2 Two-photon probe for real-time monitoring of intracellular calcium ions, method for preparing the probe and method for real-time monitoring of intracellular calcium ions using the probe |
| 06/30/2009 | US7553992 Crystal form; controlled release tablet of bupropion hydrobromide for reducing the ratio of the maximum/minimum plasma bupropion hydrobromide concentration (Cmax/Cmin) while maintaining bupropion plasma levels within the therapeutic window upon administration to a patient; more stable than buproin hcl |
| 06/25/2009 | WO2009077394A1 Azomethine direct dyes or reduced precursors of these dyes obtained from 5-(2-hydroxyethylamino)-2-methylphenol, and dyeing process using these dyes and precursors |
| 06/25/2009 | WO2009077393A1 Azomethine direct dyes or reduced precursors of these dyes obtained from 2-chloro-3-amino-6-methylphenol, and hair dyeing method starting from these dyes and precursors |
| 06/23/2009 | CA2214131C Trisubstituted phenyl derivatives |
| 06/18/2009 | US20090156653 such as 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentane-1-ol, used for treating autoimmune diseases, rheumatoid arthritis, psoriasis, dermatitis, asthma, hay fever or rejection of organ or bone morrow transplantation; side effect reduction |
| 06/10/2009 | CN100497295C Process for the preparation of N-monosubstituted beta-amino alcohols |
| 06/03/2009 | CN101448778A Inhibitors of POLO-like kinases |
| 06/03/2009 | CN101445486A Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone |
| 06/03/2009 | CN100494203C Functionalized ionic liquids, and methods of use thereof |